Current Trends in Extracellular Vesicle Research on Neuroscience from ADPD2021 Meeting
Author Information
Author(s): Ikezu Tsuneya
Primary Institution: Mayo Clinic Florida
Conclusion
The study highlights the potential of extracellular vesicles as biomarkers and therapeutic targets in Alzheimer's and Parkinson's diseases.
Supporting Evidence
- Blood neuron and astrocyte-specific EVs are useful for diagnosing brain atrophy and cognitive dysfunction in Alzheimer's and Parkinson's diseases.
- CSF-derived EVs from Parkinson's disease patients can induce PD-like symptoms in animal models.
- Unique miRNAs in CSF-derived EVs from frontotemporal dementia patients can modulate neuronal activities.
Takeaway
Scientists are studying tiny bubbles called extracellular vesicles that can help us understand and diagnose brain diseases like Alzheimer's and Parkinson's.
Methodology
Various studies presented at the ADPD2021 meeting involved isolating extracellular vesicles from biological samples and analyzing their contents and effects in animal models.
Participant Demographics
The study involved 350 patients from The Baltimore Longitudinal Study of Aging cohort, including individuals with Alzheimer's disease and mild cognitive impairment.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website